Article Text

PDF
Three more benzodiazepines

Abstract

Flunitrazepam, bromazepam and alprazolam have been launched recently onto the already overloaded benzodiazepine market. Do they provide any real therapeutic advantages?

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.